COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ DE PRESSE
Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031
Medartis Holding AG launches a private placement offering of approximately CHF 115 million in senior convertible bonds due 2031, to be used for general financing and acquisitions. BofA Securities Europe SA and Zürcher Kantonalbank serve as Joint Bookrunners -
COMMUNIQUÉ DE PRESSE
aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
aap Implantate AG receives 100% approval to amend terms of mandatory convertible bond 2023/2028. Bondholders granted early conversion option without lock-up period. Strong support from creditors -
-
COMMUNIQUÉ DE PRESSE
General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90 (previous year: CHF 0.90)
General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90. Shareholders vote on various proposals, including discharge of Board, dividend payout, and re-election of Board members -
-
-
-
COMMUNIQUÉ DE PRESSE
Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland
Xlife Sciences AG announces collaboration agreement between its portfolio company FUSE-AI GmbH and T-Systems Switzerland to distribute AI-powered software for radiology clinics. The partnership aims to increase efficiency and reduce misdiagnoses -
COMMUNIQUÉ DE PRESSE
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Moderna, Inc. announced interim data for mRNA-3927 therapy for propionic acidemia published in Nature, showing signs of clinical benefit and safety. Ongoing global trial evaluates safety and efficacy in participants with PA
